• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Jazz Pharmaceuticals

Jazz Pharmaceuticals

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  1. Jazz Pharmaceuticals Announces Pricing of $500 Million of Exchangeable Senior Notes

    Jazz Pharmaceuticals Announces Pricing of $500 Million of Exchangeable Senior Notes

  2. Jazz Legend 'Fats' Waller to be Celebrated With Fresh Spin

    Jazz Legend 'Fats' Waller to be Celebrated With Fresh Spin

  3. Natixis Global Asset Management Releases New Signature Sound Composed by Berklee College of Music Student Andres Villareal

    Natixis Global Asset Management Releases New Signature Sound Composed by Berklee College of Music Student Andres Villareal

  4. Research and Markets: Internet Music Radio Programmers 2014 - 2017: Music Plays and Monetization Mainstays

    Research and Markets: Internet Music Radio Programmers 2014 - 2017: Music Plays and Monetization Mainstays

  5. UPDATE: U.S. markets' technical backdrop strengthens

    UPDATE: U.S. markets' technical backdrop strengthens

  6. A Young Power Couple's Kickstart Portfolio

    With "massive" student debt loads receding in the rearview mirror, a young professional couple fires up their investment plan.

  7. TowerJazz Reports Second Quarter 2014 Results

    TowerJazz Reports Second Quarter 2014 Results

  8. Gross: Economy Can't Survive Much Higher Rates

    During his keynote presentation at the Morningstar Investment Conference, the PIMCO manager made the case that high debt levels and a need for financial stability mean that central banks should keep real rates close to zero for some time.

  9. Morningstar Indexes: Weekly Market Report

    Week ending Sept.29: Investors stay optimistic amid doom and gloom.

Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.